{
    "2020-03-27": [
        [
            {
                "time": "",
                "original_text": "基金投资正常退出 药明康德维京拟减持药明康德(02359)不超过1651.13万股A股 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "维京",
                        "A股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：WuXi AppTec (BVI)拟减持不超1651.1265万股 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "WuXi AppTec",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：临床和CDMO提供增长弹性，长尾战略效益逐步显现",
                "features": {
                    "keywords": [
                        "药明康德",
                        "临床",
                        "CDMO",
                        "增长弹性",
                        "长尾战略"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：股东拟减持不超1%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：股东WuXi AppTec (BVI) Inc拟减持不超1% 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "WuXi AppTec",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股资金面转暖 多路“人马”竞逐热点",
                "features": {
                    "keywords": [
                        "A股",
                        "资金面",
                        "转暖",
                        "热点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股资金面转暖，多路“人马”竞逐热点",
                "features": {
                    "keywords": [
                        "A股",
                        "资金面",
                        "转暖",
                        "热点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}